دانشگاه علوم پزشکی ایران
Iran University of Medical Sciences

Department of Medical nanotechnology

 | تاریخ ارسال: ۱۳۹۸/۶/۲۹ | 


Welcome to the Iran University of Medical Sciences Department of medical nanotechnology.Establishment of this department and strong support for its growth reflects the core goals of IUMS: to promote cross-disciplinary research and education at the intersection of medical nanotechnology and train professionals at M.Sc. levels who conduct fundamental and applied research in order to create knowledge and wealth to both governmental organizations as well as private section. Our faculty and students have a variety of backgrounds, but all are dedicated to improving human health through application of fundamental and applied medical nanotechnology. principles. The wide network of collaboration that we established with national and international scientists helps to perform the research at the highest possible standards. Our research activities are mainly focused on design and synthesis of nanostructured drugs, targeted drug delivery based on nanotechnology, Gene delivery by using nanoparticles, Toxicology of nano-materials, Medical implants based on nano-materials, Nanotechnology in regenerative medicine, stem cell technology and tissue engineering, Nano-biosensors, Nano-scale modeling, Applications of core-shell nanostructures in hyperthermia and microfluidic.
 
 We run one postgraduate MSc program in medical nanotechnology, which received approval from the National Board of medical nanotechnology of Ministry of Health and Medical Education.
Our students have the opportunity to acquire cutting-edge research skills, as well as hands-on nanotechnology skills. We strive to ensure that all our students have a strong education with teaming and leadership skills and involvement in student activities. We believe that emphasizing these areas will make our students well qualified to to create knowledge and wealth in this filed.
We have a unique team of outstanding scientists who are eager to address the most complex human disease conditions by a cross-disciplinary approach ranging from fundamental scientific discoveries to applied and medical research. Medical nanotechnology is one of the most exciting and rewarding area of medical and nanotechnology sciences, which provides enormous opportunities for making improvements in human health. Our goal is to develop creative ways to discover and apply medical nanotechnology cures for human diseases, as well as create value and wealth for our graduated students.
 
If you would like to become more involved with our departmental activities or learn more about our programs, please feel free to contact us.
 
Dr. Bita Mehravi, PhD
Department Head
 

دفعات مشاهده: 471 بار   |   دفعات چاپ: 16 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر

معرفی مدیر گروه

 | تاریخ ارسال: ۱۳۹۶/۸/۱۶ | 



 

Dr. Bita Mehravi PhD


Position: 
Department Head

Biography: 
Dr. Bita Mehravi has received her PhD degree from Shahid behest medical science in Iran 2013. Her expertise is mainly focused on design and synthesis of nanstructures , Medical implants based on nano-materials and targeted drug delivery and cellular and molecular imaging. Her publications, including book chapters, editorials, abstracts and original articles are published in collaboration with an international network of the world's high-profile scientists. Some of her research outputs have been patented for commercial purposes. Dr. Mehravi serves on the editorial boards of several journals and regularly reviews for many publishers. She has a long-standing experience in teaching the basic and advanced courses of nanotechnolofy to postgraduate students and to physicians in training. Therefore, she has matured to act as a linker between scientists with different backgrounds.
She is one of the first graduated students in medical nanotechnology and who started working on medical nanotechnology in Iran and has highly shaped and promoted the academic and industrial aspects of this field in the country. Dr. Mehravi create a medical nanotechnology network in IUMS and stablish a knowledge based company in IUMS. She employed medical nanotechnology graduated student in this company.

Research: 
The multidisciplinary field of medical nanotechnology aims to design and synthesis of nanostructures , Medical implants (special ocular implants) based on nano-materials and targeted drug delivery and imaging.
 
Qualifications:
2018: MBA, Faculty of Entrepreneurship, Tehran University
2013: PhD, Shaid beheahti medical university, IRAN


Teaching:
  • Principles of nanomedicine
  • Principles targeting drug delivery
  • Nanomaterial and nanostructures
  • Synthesis of nanomaterial and nanostructures
  • Characterization methods of nanomaterial and nanostructures
  • Business and entrepreneur in medical nanotechnology
  • Business Administration (MBA)
  • Intellectual properties
  • Entrepreneurship
 
Other Work Experience:
Head of medical nanotechnology department, Faculty of Advanced Medical Technologies, IUMS
Deputy of Education, Faculty of Advanced Medical Technologies, IUMS
 
Director of Brilliant Talent Office IUMS

Publications:

·Chitosan-alginate nano-carrier for transdermal delivery of pirfenidone in idiopathic pulmonary fibrosis, 2018, International Journal of Biological Macromolecules, 8130(18)31161-9

·Investigating the effect of near infrared photo thermal therapy folic acid conjugated gold nano shell on melanoma cancer cell line A375, 2019, Artificial cells, nanomedicine and biotechnology, https://doi.org/10.1080/21691401.2019.1593188

 
  • NIR triggered glycosylated gold nanoshell as a photothermal agent on melanoma cancer cells,2019, Artificial cells, nanomedicine and biotechnology https://doi.org/10.1080/21691401.2019.1593187

·Gold nanorods reinforced silk fibroin nanocomposite for peripheral nerve tissue engineering applications, 2019, International Journal of Biological Macromolecules, https://doi.org/10.1016/j.ijbiomac.2019.02.050

·Preparation of Bio-Inspired Melanin Nanoplatforms Chelated with Manganese Ions as a Potential T1 MRI Contrast Agent. 2019, Materials Science inc. Nanomaterials & Polymers, 4, 5860–5865

·Acute Toxicity Evaluation of Glycosylated Gd3+-Based Silica Nanoprobe: Molecular Imaging and Biology (SPRINGER) : August 2017, Volume 19, Issue 4, pp 522–530

  • Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma, Int J Biol Macromol. 2017 Nov 14. pii: S0141-8130(17)33504-3. doi: 10.1016/j.ijbiomac.2017.11.090
   
  • Structure-based pharmacophore design and virtual screening for novel potential inhibitors of epidermal growth factor receptor as an approach to breast cancer chemotherapy, Mol Divers. 2017 Dec 2. doi: 10.1007/s11030-017-9799-7
 
 
  • In Vitro Evaluation of Gd3+-Anionic Linear Globular Dendrimer-Monoclonal Antibody: Potential Magnetic Resonance Imaging Contrast Agents for Prostate Cancer Cell ImagingMolecular Imaging and Biology December 2015, Volume 17, Issue 6, pp 770–776|
 
  • Cellular uptake and imaging studies of glycosylated silica nanoprobe (GSN) in human colon adenocarcinoma (HT 29 cell line), Int J Nanomedicine. 2013;8:3209-16. doi: 10.2147/IJN.S44815. Epub 2013 Aug 21.
 

·Conjugation of glucosamine with Gd3+-based nanoporous silica using a heterobifunctional ANB-NOS crosslinker for imaging of cancer cells, Int J Nanomedicine. 2013;8:3383-94. doi: 10.2147/IJN.S44829. Epub 2013 Sep 24.

 
  • Cellular uptake, imaging and pathotoxicological studies of a novel Gd[iii]–DO3A-butrol nano-formulation, RSC Adv., 2014,4, 45984-45994 
 
  • Synthesis and Development of MSN-Gd3+-C595 as MR Imaging Contrast Agent for Prostate Cancer Cell Imaging, Current Molecular Imaging, Volume 3, Number 1, March 2014, pp. 43-51(9)
 

·New salen-type manganese(III) Schiff base complexes derived frommeso-1,2-diphenyl-1,2-ethylenediamine:In vitroanticancer activity, mechanism of action, and molecular docking studies, Journal of Coordination Chemistry, 06 April 2015 Volume 68, 2015 - Issue 9,

 
  • In vitro Evaluation of Gadolinium-Silica Mesoporous Nanoparticles- Monoclonal Antibody: Potential Nanoprobe for Prostate Cancer Cell Imaging, Current Molecular Imaging, Volume 4 , Issue 1 , 2015
 
  • Crystal structures and in vitro anticancer studies on new unsymmetrical copper(II) Schiff base complexes derived from meso-1,2-diphenyl-1,2-ethylenediamine: a comparison with related symmetrical ones, Journal of Coordination Chemistry,2016,  Pages 2469-2481
 
  • Piperazine and its carboxylic acid derivatives-functionalized mesoporous silica as nanocarriers for gemcitabine: Adsorption and release study, Materials Science and Engineering C 49 (2015) 66–74
 
  • Bioactive salen-type Schiff base transition metal complexes as possible anticancer agents, Iranian Journal of Pharmaceutical Research (IJPR),2017,in press
 
  • On-demand Cellular Uptake of Cysteine Conjugated Gadolinium based Mesoporous Silica Nanoparticle with breast cancer-cells, 2018, Iranian J Pharmacol Ther. 2018 (March);16:1-8.




Emails:
mehravi.b iums.ac.ir
bmehravi yahoo.com

Tel: (+98-21) 8862 2755

Fax: (+98-21) 8862 2533

Office Hours: Mondays 1:00-3:00 pm
 


 

دفعات مشاهده: 2719 بار   |   دفعات چاپ: 136 بار   |   دفعات ارسال به دیگران: 0 بار   |   0 نظر